FORMULARY DECISION
Rituximab : MabThera
591/09 : Relapsed/refractory CLL
We have found 39 results when searching "Rituximab"
591/09 : Relapsed/refractory CLL
675/11 : Follicular lymphoma patients responding to induction therapy
894/13 : In combination with glucocorticoids for the induction of remission in adult patients with severe, active granulomatosis with polyangiitis (Wegener's) (GPA) and microscopic polyangiitis (MPA).
975/14 : For non-Hodgkin' s lymphoma (NHL) in adults: - previously untreated patients with stage III-IV follicular lymphoma in combination with chemotherapy; - maintenance therapy is indicated for the...
SMC2165 : In combination with glucocorticoids, for the treatment of adult patients with severe, active granulomatosis with polyangiitis (Wegener’s) (GPA) and microscopic polyangiitis (MPA).
SMC2193 : Treatment of patients with moderate to severe pemphigus vulgaris.
In combination with bendamustine for first-line treatment of chronic lymphocytic leukaemia.
Treatment of primary mediastinal B-cell lymphoma.
Treatment of central nervous system lymphoma.